Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
Margaret C. Fang(San Francisco General Hospital), Daniel E. Singer(Kaiser Permanente), Jonathan Rosand(Harvard University), Steven M. Greenberg(Columbia University), Elaine M. Hylek(Boston University), Yuchiao Chang(Harvard University), Alan S. Go(Kaiser Permanente)
Cited by 532
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k